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Abstract
Recent statistics provided by the American Lung Association assert that over 400,000
Americans die every year from lung disorders and more than 35 million are now living
with symptoms of lung disease. Mortality rates of heart disease and certain cancers have
declined in recent years partly due to improvements in diagnostic testing and the
development of targeted medical technologies. Such improvements have not translated
over to the treatment of lung disease and lung cancer. The goal of the artificial respiration
project is to create a self-contained, mobile oxygen supply that is suitable for
implantation and that can potentially replace acute or chronically disabled lungs.
A novel microfluidic device for the oxygenation of whole blood has been developed. The
device couples a semiconductor, titanium dioxide (TiO2), thin film that generates oxygen
through photocatalysis with a microfluidic network that facilitates diffusion of the
dissolved oxygen to red blood cells. While true pulmonary respiration relies on passive
diffusion of oxygen gas from the environment to the blood, the proposed device differs in
that it generates oxygen directly from the water in blood plasma. This thesis focuses on
the work done to fabricate and characterize the semiconductor photocatalyst, design the
integrated microfluidic chip, and validate its capacity to oxygenate blood in real-time.
Blood oxygenation experiments show that the microfluidic device exhibiting the best
performance produced 4.06 mL of oxygen per 100 mL of blood, nearly two-thirds of the
oxygen transferred in the lung. The flux of oxygen at the photocatalyst surface was 1.11 x
10-3 mmol 02/ (cm2 - min). The 02 flux is nearly two orders of magnitude larger than that
of any other fluidic device for blood oxygenation to date. The results from the proof-of-
concept microfluidic device are promising and are a step towards the realization of a
photocatalytic artificial lung.
Thesis supervisor: Todd Thorsen
Title: Associate Professor of Mechanical Engineering
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Chapter 1
Introduction
Every year, almost 400,000 Americans die from lung disease, and it is the number three
killer in the country (behind heart disease and cancer), responsible for 1 in 6 deaths.' The
lung disease death rate has been increasing over the last decade, while death rates due to
other leading causes of death have been declining. Asthma and chronic obstructive
pulmonary disorder (COPD) are the most common obstructive lung diseases, with more
than 12 million people currently diagnosed with COPD and another 12 million who likely
have the disease without knowing it.2 Additionally, the National Heart Lung and Blood
Institute estimates that about 190,000 Americans are affected annually by acute
respiratory distress syndrome (ARDS) - a life-threatening condition in which normal gas
exchange is compromised by severe buildup of fluid in both lungs.' Furthermore, lung
disease and various forms of respiratory problems constitute one leading cause of death
of babies under the age of one. These disheartening statistics, as well as the fact that lung
disease costs the US economy approximately $154 billion in direct and in-direct health-
care expenditures, 1 provides us the incentive to develop solutions to address chronic and
acute respiratory illnesses.
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Figure 1.1: Age-adjusted Cancer Death Rates for Males in the US, 1930-2004. This
graph, reproduced from the American Cancer Society 2008 Cancer Facts & Figures
Report, shows that cancer of the lung and bronchus remains one of the leading causes
of cancer death.
Mortality rates of heart disease and certain cancers have declined in recent years partly
due to improvements in diagnostic testing and the development of targeted medical
technologies. Such improvements have not translated over to the treatment of lung
disease and lung cancer. Current treatments include medication (e.g. corticosteroids to
reduce inflammation in the airways and antibiotics to treat bacterial infections),
mechanical ventilation (e.g. neattive and positive pressure devices that increase the
amount of air moving into the lungs), oxygen therapy (e.g. extracorporeal membrane
oxygenation (ECMO)), and surgery (e.g. lung transplantation and lung reduction surgery
to excise diseased tissue). Non-surgical treatments, although they provide brief respite
from the symptoms of respiratory disease, are not sufficient standards of care for chronic
sufferers. For example, in ECMO, a treatment technique in which cannulae are inserted
into the large vessels in the body and blood is pumped through gas-permeable
membranes in order to facilitate oxygen and carbon dioxide exchange, there is a
significant risk to the patient of thrombosis (blood clotting), infection, and bleeding under
anticoagulant medication. 3 Other downsides to ECMO, which has been used consistently
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since the early 1970s, include the requirement of a large pumping power to flow the
blood through the machine, biofouling on the machine's membranes due to protein and
platelet adhesion, and high cost of operation.4
Select patients with end-stage lung disease, for whom conventional therapies will not
improve life expectancy or alleviate symptoms, lung transplantation remains the only
option. However, according to the Scientific Registry of Transplant Recipients, 14% of
those on the national waitlist between 2007 and 2008 died before they could receive a
lung. For those who received a graft, the survival rate 3 years after implantation
plummeted by 30%.5 Even in the case where lung transplant is successful, patients must
take autoimmune drugs for the rest of their life.6 The transplanted lung is "foreign" to the
body and, as a result, there is the possibility of rejection. Patients who receive new lungs
must take the autoimmune drugs to suppress the body's natural rejection process.
1.1 Overview of the microfluidic device for
photocatalytic blood oxygenation
This thesis discusses a novel approach to developing a device to oxygenate blood - an
"artificial lung". As discussed earlier, current treatments for lung disease are not
completely effective, nor are they sustainable in the long term. The goal of the artificial
respiration project is to create a self-contained, mobile oxygen supply that is suitable for
implantation and that can potentially replace acute or chronically disabled lungs. The
device that is presented in this thesis has the potential of sustaining human respiration
because no refillable tank of gas or pumping power is involved. The oxygenation of the
blood works on the following principle: oxygen is generated in the fluid stream directly
from the dissociation of water in the blood plasma.
The device couples a semiconductor titanium dioxide (TiO2) thin film that generates
oxygen through photocatalysis with a microfluidic network that facilitates diffusion of
the dissolved oxygen to red blood cells. When the thin film semiconductor is irradiated
with ultraviolet (UV) light (of wavelength X = 365 nm), electron vacancies, or holes, are
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generated and migrate toward the surface to provide sites for oxidation. Blood flowing in
the PDMS microchannel is in direct contact with the TiO2 photocatalyst and the water
present in blood is oxidized to aqueous oxygen, ready to bind to red blood cell
hemoglobin. In this manner, the proposed implantable device will be capable of
saturating flowing blood with oxygen in real-time. Real-time oxygenation means that
with one pass through the device, blood can go from venous levels of oxygen saturation
to arterial levels.
As this is a project that resides at the intersection of multiple disciplines, research in
artificial respiration technology can lead in several directions. The breakdown of the
areas in which we are looking to make developments are as follows:
1) Optimizing the function of the thin film semiconductor photocatalyst
The generation of oxygen from photocatalytic water dissociation needs to be
sufficient in order to sustain cellular respiration in the tissues of the body. Our goal is
to maximize the oxidative potential of the photocatalyst by optimizing thin film
processing.
2) Microfluidic channel scaling and geometry to improve mass transport
Previous studies have investigated microcapillary branching in channels molded in
polydimethylsiloxane (PDMS), mimicking the architecture of pulmonary capillaries.
The blood flow in these designs, however, is limited due to high rates of hemolysis
and intraluminal clotting.4'7
3) Optics module to efficiently deliver UV light to semiconductor
The semiconductor is activated by light in a narrow band within the UV range (with a
peak activation at X = 365 nm) and there is a maximum flux of photons needed to
generate electron holes continuously. An optics module needs to be developed in
order to minimize the power required to operate the device and to efficiently relay the
light to where it is needed (the photocatalyst) and shield the light from areas where it
can potentially cause damage.
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4) Integrated design of all components
The work discussed in this thesis encompasses goals (1) and (4). Experiments with our
design have shown that (a) we can produce a constant flux of 02 from the photocatalyst
over time thus allowing steady-state operation and (b) blood can be fully oxygenated in
real time, although only at slow flow rates at present.
1.2 Organization
The thesis will be organized as follows:
Chapter 2 provides relevant background in order to understand how blood oxygenation
occurs in vivo and how photocatalysts are employed to produce oxygen, as it relates to
the design goals of the microfluidic device for artificial respiration.
Chapter 3 discusses the fabrication of the thin film photocatalyst and its characterization.
The goal is to develop a deposition protocol to produce a highly active film.
Chapter 4 proposes a design for a device that incorporates a highly active thin film
photocatalyst into a microfluidic chip, details its fabrication procedure and validates
device function.
Chapter 5 presents a brief summary of the thesis, discusses ongoing work that is being
done on the project, and provides recommendations for future research.
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Chapter 2
Background
The microfluidic device for artificial respiration is the result of a complex integration of
technologies from various fields. For the proper design of a microfluidic device, the
requisite knowledge of biology, biochemistry, materials science, and micro- and nano-
fabrication are necessary. For this project, in particular, a brief review of respiration,
photocatalysis, and microfluidics is relevant.
2.1 Respiration
Respiration can be divided into two phases: internal and external. Internal, or cellular
respiration, is the set of metabolic reactions that takes place in the cells once it has
acquired dissolved oxygen gas to convert carbohydrates into biochemical energy. The
mechanisms of cellular respiration are well known and are not studied in this work.
External, or pulmonary, respiration is of interest at present because most patients of lung
disease suffer when pulmonary respiration is affected. The following is a brief, yet
critical, overview of the fundamentals of respiration as it pertains to the issues addressed
by the device for artificial respiration.
2.1.1 Pulmonary respiration
The function of the lungs is to facilitate gas exchange with the environment-oxygen to
venous blood and carbon dioxide out of the body. Although the lungs have other
functions (metabolizing compounds and filtering unwanted materials from blood
circulation, for example), the main purpose of the organ is to get oxygen to the blood
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where it can be taken to the tissues of the body for cellular respiration and release the
byproduct, carbon dioxide.
The exchange of oxygen and carbon dioxide relies on a pressure differential and simple
gas diffusion through thin membranes. When one inspires, the volume of the thoracic
cavity increases because of the displacement of the diaphragm and the rising of the ribs.
The pressure in the lung's internal cavity decreases, inducing a rush of air into the
airways. The average person breathes in about 4 liters of air into her lungs per minute and
the heart pumps approximately 5 liters of blood per minute through the pulmonary
cavity.8 The large volume of fluid, both air and blood, must efficiently undergo an
exchange of gases in a short period of time. The unique structure of the lung allows for
efficient and rapid oxygen and carbon dioxide exchange.
According to Fick's law of diffusion, the flux of gas transport through a tissue is
proportional to surface area and inversely proportional to the thickness of the membranes.
The membranes constituting the blood-gas barrier in lungs are very thin (dimensions as
small as 0.3 tm in certain areas) and the barrier has a total surface area between 50 and
100 square meters.9 The average lung, however, only has about 10% solid tissue. Three-
hundred million tiny air sacs, called alveoli, are responsible for the prodigious surface
area and the total volume of the alveoli amounts to 4 liters.8'9 To provide some
perspective, a sphere of the same volume would have a surface area of only 1/100 th of a
square meter. The alveoli are surrounded by webs of tiny capillaries measuring 5-10 pm
in diameter. Since erythrocytes are 6-8 jtm in diameter, they enter the capillaries in single
file, allowing for a direct path for oxygen diffusion to the cells. Refer to Figure 2.1, an
electron micrograph showing a pulmonary capillary (C) that resides in the thin blood-gas
barrier. The arrow indicates the diffusion path from the alveoli (the white void) to the
erythrocyte (EC), or red blood cell.
As is evident from the micrograph, the membrane through which oxygen must diffuse
can be as thin as a 0.3 im. The diffusion coefficient, D, of a molecule is proportional to
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the gas solubility, Sol, and inversely proportion to the square of the molecular weight,
MW:
SolDoc
The time required for diffusion scales with the square of the membrane thickness, L, and
the inverse of the diffusion constant:
L
2
D
Abnormalities common to lung disease often result in the mucosal thickening of the
blood-gas barrier, essentially increasing the value of L, thus impeding the diffusion of
gases across it. As mentioned previously, chronic sufferers of lung disease often have
infections that thicken the layer of viscous fluid in their lungs, making it very difficult for
them to breathe.
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Figure 2.1: Electron micrograph showing a pulmonary capillary in the alveolar wall.
[Reproduced from West, 2000]
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2.1.2 Blood oxygenation
The structure and function of hemoglobin and myoglobin have been investigated
thoroughly by biochemists over the last five decades. They were the first proteins whose
three-dimensional structures were determined ' "11 and, as a result, the reversible binding
of a protein to ligand is now very well understood. Hemoglobin is a protein residing in
red blood cells containing four identical subunits that contains an iron-porphyrin heme
group and functions in the transport of oxygen. Myoglobin, although structurally similar
to a single subunit of hemoglobin, is the oxygen-storing protein in muscles.
Oxygen has a low solubility in aqueous solutions and cannot be carried to the tissues of
the body in sufficient amounts simply by dissolution in blood serum. The solubility of
oxygen in blood is only 0.0031 mL 02/100 mL blood/mm Hg. Small organisms have
found it possible to rely solely on the diffusion of oxygen through membranes, but that
alone cannot sustain larger multicellular organisms as diffusion is ineffective over
distances greater than a few millimeters. Birds and mammals employ hemoglobin by
exploiting the strong tendency of oxygen to bind to certain transition metals, like iron and
copper. 12 The protein prosthetic group, heme, consists of an organic ring, protoporphyrin,
that has a single iron atom in the ferrous state (Fe2+) at its center. Fe2+ is capable of
binding oxygen reversibly and more than 90% of the oxygen in blood serum is that which
is bound to the hemoglobin.
The figure below shows the sigmoidal oxygen affinity curve for hemoglobin. The
hemoglobin in blood must bind oxygen efficiently in the lungs, while releasing the
oxygen (have decreased affinity for binding) in the tissues of the body. Allosteric
proteins, such as hemoglobin, are capable of having variable affinities to ligands because
the binding of a ligand to one site causes conformational changes that affect binding to
another site. In the case of hemoglobin, there are four binding sites for 02 and, as more
oxygen molecules bind to it, the protein transitions from a low-affinity state to a high-
affinity. Therefore, as oxygen binds to hemoglobin in the lungs where the partial
pressure, pO2, is about 13.3 kPa, its affinity increases and more oxygen binds.
Conversely, as the erythrocytes move to the tissues where pO2 is approximately 4 kPa,
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oxygen releases itself from hemoglobin and the binding affinity decreases. 12 Figure 2.2
also shows that approximately 10% of the oxygen concentration in blood is dissolved in
the plasma, while the other 90% is combined with hemoglobin.
100
I 14•1
2E
20 40 60 8O 100 ~m0
P, (mmn Hg)
Figure 2.2: 02 dissociation curve. The solid line is for pH = 7.4, pCO 2 = 40mm Hg, and
temperature = 37°C. The dotted line is the oxygen concentration in 100 mL blood.
[Reproduced from West, 2000]
Normal erythrocytes (red blood cells) are small biconcave disks (about 6 to 9 ,m in
diameter) that are vestigial cells, unable to reproduce and survive for more than 120
days.10 Their sole function is to carry hemoglobin. In arterial blood, hemoglobin is 96%
saturated with oxygen and venous blood is about 64% saturated. Therefore, about every
100 mL of blood flowing from the lungs, throughout the body, and then back again
releases about 6.5 mL 02 in the process. 9 This serves as a benchmark for our
photocatalyst design as one of the ultimate goals of the microfluidic device for artificial
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respiration is to achieve enough oxygen yield from the photocatalytic reaction to sustain
cellular respiration in the body.
2.2 Photocatalysis
The breakthrough work of Fujishima and Honda in 1972,13 in which they achieved
ultraviolet light-induced water cleavage with the use of titanium dioxide (TiO2) in an
electrochemical cell, has drawn considerable attention in recent years to the "acceleration
of a photoreaction by the presence of a catalyst"' 4 or photocatalysis. The possibility of
solar energy conversion by semiconductors or sensitizers is of increasing interest because
of the current effort to create renewable energy sources to replace the use of fossil fuels.
Exhaustion of natural energy sources and environmental pollution has almost necessitated
these technological efforts. The amount of solar light impinging on the earth's surface is
more than 1024 J/year, 104 times that of the world's energy consumption.15,16
Consequently, harnessing solar energy in sustainable and environmentally-friendly
processes has become one major effort to decrease the global dependence on fossil fuels.
The need for efficient production of fuels from inexpensive materials and with minimum
waste generation has been the motivator for many research projects in energy. An
example of simple, and highly desirable, reactions is the oxidation reaction of water into
H2 and 02 and the reduction of CO2 into methanol driven by light. The effect of light in
these cases is to create electron-hole pairs in catalysts that, like the charge separation in a
battery, provide the driving energy for reactions to take place. The analogous model often
used for these energy conversion systems is biological photosynthesis.
During the process of photosynthesis, plants and certain species of bacteria capture
energy from sunlight and produce useable fuels that help them grow. In this process, CO2
is reduced to sugar and carbohydrates in a rather complex set of reactions: pigments
absorb energy from sunlight, that energy oxidizes water to produce oxygen, and the
electrons from the oxidation reaction contribute to the formation of carbohydrates. The
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fundamental aspect of the energy conversion process is the removal and then separation
of the electrons from their source, H20. The separation of charges is accomplished by the
presence of very thin lipid membranes in the organelles of plant cells through a series of
intermediate redox reactions involving proteins with metal complexes. Photocatalysis
essentially replicates this first phase of the photochemical solar energy conversion of
photosynthesis - light induced water splitting and charge separation - without carrying
out the dark reactions that produce carbohydrates from CO 2. Photosynthesis is the most
efficient and successful solar conversion system available, and thus serves as an ideal
model for photocatalysis.
2.2.1 Semiconductor photocatalysis
Photocatalysts are used to induce redox reactions because solar energy alone cannot
excite electrons of simple molecules to higher energy states. Semiconductors are uniquely
positioned to be used as photocatalysts because of their electronic structure. By
definition, semiconductors are materials with an electrical conductivity between that of
conductors and insulators. Upon illumination of these materials with light having energy
greater than the bandgap energy, Ebs, electrons from the valence band elevate to higher
energy levels leaving behind electron vacancies or "holes". Energy or current is carried
by electrons and holes, and the rate at which they move can be precisely tuned by
processes like doping, in which impurities are intentionally added to the bulk material to
change its electronic structure. The photoexcitation of semiconductors is an effective
means of initiating important and normally energetically unfavorable redox reactions.
The overall photocatalysis reaction in a semiconductor is as follows:
A + D semiconductor + light 2 Ebg A- + D+
where A is an electron acceptor and D is an electron donor. 14,16 Upon excitation of light
with energy greater than Ebg, electron-hole pairs can be generated. Either spontaneously
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or under the action of an electric field, the electrons and holes generated move in opposite
directions, either further into the bulk or to the surface of the photocatalyst, where an
electron acceptor can be reduced (refer to Figure 2.3, reaction (c)) and where a donor can
be oxidized (Figure 2.3, reaction (d)). Otherwise, recombination of the electron-hole pairs
can occur within the bulk, losing the opportunity for their use in any redox reactions. This
is of significance because the recombination of electron-holes is a severe limitation in
photocatalysis.
Figure 2.3: illustration of the major processes occurring on a semiconductor particle
following electronic excitation. Electron-hole recombination can occur at the surface
(reaction (a)) or in the bulk (reaction (b)) of the semiconductor. At the surface of the
particle, photogenerated electrons can reduce an electron acceptor A (reaction (c))
and photogenerated holes can oxidize an electron holes can oxidize an electron donor
D (reaction (d)). [Reproduced from Mills and Le Hunte, 1997]
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2.2.2 Electron-hole recombination
It is often a challenge to predict the yield of the photocatalytic redox reactions. That is, it
is difficult to determine the lifetime of the oxidized and reduced species that form after a
semiconductor photocatalyst has been activated by light. Energy absorbed by the material
results in the formation of electron-hole pairs but, if the pairs do not migrate far or
recombine (reactions (a) and (b) in Figure 2.3) before reaching the surface of the
semiconductor, the energy is simply released as heat. Unlike the formation of the
electron-hole pairs, it is not easy to predict the recombination rate directly. Photocatalytic
semiconductors have generally been found to have low quantum efficiency because the
recombination of electron-holes shortly after they are generated predominates the
photocatalytic activity.1 7 An ordinary semiconductor redox reaction has the efficiency of
about 30%, meaning that 70% of the electron-hole pairs that are generated recombine
before any reaction takes place. 16 Thus, for the design and proper function of a
semiconductor photocatalyst, recombination cannot be ignored.
Research in the field of semiconductor photocatalysis has focused on designing materials
with high activity. It is well known that photocatalytic activity depends on the surface
area and particle size of semiconductor powders, the material's crystal structure, 14 and
adjustment of their bulk properties.18 The reason these properties have a significant effect
on photocatalytic activity is because they each serve to segregate electrons and holes
and/or reduce the probability of recombination. As the particle size decreases, the
photocatalytic activity of a semiconductor increases due to the increase in surface area to
bulk volume ratio. Consequently, redox reactions are induced readily because the
diffusion distance (and thus, probability of recombination) for photogenerated electron-
hole pairs is minimized. For this reason, photocatalysts are often employed in powder
form or, in some instances, as thin films with high surface roughness. As for crystal
structure, it has been shown that high crystallinity has the effect of increasing
photocatalytic activity in metal oxide semiconductors. 17 '19,20 Many studies have shown
that annealing improves the crystallinity of photocatalysts and reduces crystal defects-
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assumed sites of electron-hole pair recombination. 14.16 The importance of crystal structure
will be elaborated upon in a later chapter.
Recently, doping of photocatalytic semiconductors, like TiO 2, has been attempted to
manipulate bandgaps such that the materials are highly reactive under visible light.
18
,
21
Although materials with changed bulk properties suffer from thermal instability and a
possible increase of electron-hole recombination centers, it has also been shown that the
photocatalytic activity of TiO 2 is remarkably enhanced with the addition of small
amounts of noble metals.' 8 This is explained by the quick segregation of the electrons and
holes, as the electrons are transferred to the metal particles. In the case of photo-induced
splitting of water using platinum-loaded TiO 2, for example, the holes are free to oxidize
water and the electrons on the Pt participate in H2 evolution. Recombination, in such a
case, is minimized. Figure 2.4 illustrates the decomposition of acetic acid using Pt-loaded
TiO2 particles illuminated by UV light.
OH ) c
*011
CHCHOOH *CH3 - C02
Figure 2.4: Schematic illustration of decomposition of acetic acid. [Reproduced from
Kaneko and Okura, 2002]
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The principle behind metal loading as a means of reducing the probability of electron-
hole recombination can be extended to photoelectrochemical cells. In such cells, instead
of adding metal particles to the bulk semiconductor directly, the photocatalyst is
connected via an external circuit to a metal electrode (usually made of platinum) through
which electrons can be conducted. As presented in the following section, this system can
be highly efficient in photocatalytic activity, with quantum yield reaching nearly 100%
for some single-crystal semiconductor cells. 16
2.2.3 Photoelectrochemical cells
The possibility of solar photocatalysis was first demonstrated in the late 1960s by Honda
and Fujishima when an n-type TiO2 semiconductor connected to a platinum
counterelectrode was exposed to UV light (refer to Figure 2.5).6 When irradiated with
light, current flowed from the platinum electrode to TiO 2 through an external circuit. It
was shown that oxygen evolution occurred at the TiO2 electrode and hydrogen gas
formed on the Pt electrode as per the following water-splitting reactions:
Excitation of TiO2 by light:
TiO2 + 2hv 2e- + 2h+  (Eq. 2.1)
At the TiO 2 surface:
H 2 0 + 2h+ -*0 2 + 2H +  (Eq. 2.2)
At the counter electrode:
2H + + 2e- --> H 2  (Eq. 2.3)
The overall reaction is:
1
H 2 0 + 2hv - 02 + H 2  (Eq. 2.4)
In this preliminary photoelectrochemical cell, no external voltage was applied. When the
semiconductor electrode is in contact with an electrolyte, as it is in Figure 2.5, charge
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equilibrium takes place at the interface. 16 A charge layer within the region close to the
semiconductor bends the electronic energy bands and creates a local electric field, driving
photogenerated holes toward the surface of the semiconductor and electrons into the bulk
material. In solution, the redox reactions occur readily on the surfaces of the electrodes
because the action of the electric field efficiently drives electrons and holes in opposite
directions.22
6
4 V 4
5
SLO
Figure 2.5: Electrochemical cell employing TiO2 as a photoanode. (1) n-type TiO2
semiconductor; (2) platinum counter electrode; (3) ionically conducting separator; (4)
gas buret; (5) load resistance; (6) voltmeter. [Reproduced from Fujishima, 2000]
The presence of a counter electrode and electrolyte solution are essential for high yield of
electron-hole pairs. As in the case of metal-loaded semiconductors, where small amounts
of Pt, for example, are added to the bulk material, the counterelectrode serves as the site
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for hydrogen evolution. The electrochemical cell used by Fujishima and Honda is a set-
up that motivates the design of the photocatalytic cell for artificial respiration.
2.3 Microfluidics
Microfluidics is the manipulation of fluids in micrometer-sized channels, of volumes
from 10-9 to 10-8 liters. The development of so-called labs-on-chips and micro total-
analysis systems (/TAS) has aided in the investigation of biological and chemical
synthesis and analysis. The field of microfluidics has a wide range of applications, even
those extending to optics and information technology. The scales on which these devices
are designed lend themselves well to the fabrication techniques of semiconductor and
integrated circuit technologies. Additionally, chips can be designed and fabricated
rapidly, they are inexpensive and small, and they consume low volumes of samples and
reagents. Therefore, microfluidics presents itself novel means of analysis and synthesis
on the micro-scale.
The behavior of fluids on this scale can differ significantly from the behavior of
"macrofluidics" because factors such as surface tension, energy dissipation, fluidic
resistance and electrochemical interactions dictate phenomenon at the micro level.
Microfluidics often studies these factors and how they can be exploited experimentally.
In microfluidic devices, like the one that is discussed in this thesis, two things hold true:
(i) the dimensionless Reynolds number is low and aqueous flow is laminar, not turbulent
and (ii) diffusion plays an important role in mass flow because the feature dimensions are
small.
In the case of the development of a device for artificial respiration, microfluidics plays an
important role. To begin with, the oxygen being produced by the photocatalytic
semiconductor is essentially a flux of dissolved gas that comes only from the lower plane
of the channel. In order for the oxygen to bind to the red blood cells that are flowing
above the photocatalyst, it must diffuse through the height of the channel faster than it is
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being advected by the flow. As mentioned earlier, that criterion is fulfilled if the P6clet
number is low. Second, the channels that will be molded into the polymers of the ultimate
microfluidic device design will have dimensions, geometry and branching similar to that
of capillaries. Standard soft lithography techniques will make this a feasible endeavor.
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Since the 1960s, titanium dioxide has been the focus of research on photocatalysis and
there have been many investigations into its various applications. TiO2 has been found to
be non-toxic and mechanically stable, can be fabricated at low-cost, and has a bandgap of
approximately 3 eV, ideal for excitation by light in the ultraviolet range. Titanium
dioxide employed in aqueous form, in powders and as coatings on surfaces have great
oxidative power. So far, the most active application of photocatalysis has been the
photodegradation of organic compounds. TiO 2 has been used as a coating for self-
cleaning and anti-microbial surfaces in office buildings and hospitals, and in water, air
and wastewater treatment systems.23 Two years ago, an Italian company incorporated
TiO 2 into cement to create smog-eating building materials for industrial and urban
settings.24 Titanium dioxide has also been used in anti-fogging coatings because of its
superhydrophilicity when activated by UV light25 and has been employed as a means of
killing malignant cancer cells.26 The application of most interest to this project is the use
of the metal oxide semiconductor in solar cells for oxygen and hydrogen production by
water splitting.
All of the uses of titanium dioxide in photocatalytic cell applications rely on its high
activity once irradiated by UV light. It has been reported that amorphous TiO2 has
negligible activity indicating that crystallinity improves production of electron-holes and
impedes recombination. Titanium dioxide exists in three crystal phases: rutile, anatase
and brookite. Rutile is the most thermodynamically stable, and anatase exhibits the most
photocatalytic activity, while brookite is the rarest and most inactive. Anatase and rutile
both have titanium cations coordinated to six oxygen anions in an octahedron, but the
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packing of the octahedra differ in the two crystals. 27 The surface areas of anatase crystals
tend to be greater than those of rutile as a result, and anatase films are slightly less dense.
The criteria for the titanium dioxide films that are to be employed in the microfluidic
device for artificial respiration are as follows:
(1) High crystallinity: The concern is not so much the size of the grains, but the
percent content of anatase versus other crystal phases. The presence of rutile will
decrease the activity of the overall film. Therefore, our goal is to develop a
deposition protocol to produce pure anatase thin films.
(2) Smooth films: High surface roughness or high porosity, although favorable for the
photocatalyzed splitting of water, is undesirable in biomedical applications
because of the possibility of cell adhesion and proliferation within the
semiconductor. Bio-fouling decreases the affective surface area of the
photocatalyst and therefore ought to be minimized.
The overarching goal of the artificial respiration project is to supply oxygen to the blood
stream in a closed system. In order produce enough oxygen to saturate red blood cell
hemoglobin as it is in normal pulmonary function, the chief aim is to maximize the
photocatalyst efficiency of oxygen formation. In the present chapter, the optimization and
characterization of titanium dioxide thin films fabricated using two different methods -
the sol-gel method and reactive sputtering - have been explored.
3.1 Sol-gel
The sol-gel method is a wet-chemistry technique used primarily for the fabrication of
metal oxides. The term refers to the first stage transformation of the "sol" or liquid-like
material to a more solid-like "gel". The process involves the following steps: (1)
formation of a sol containing an organometallic precursor, usually a metal alkoxide, in
solution with alcohol and/or water; (2) aging and deposition of the sol on a substrate; (3)
evaporation of the solvents, gel formation, and film solidification; and (4) heat treatment
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for the pyrolysis of residual organics, and densification and crystallization of the film. 28
The result is a thin film of metal oxide covalently bonded to the substrate. The reaction is
as follows:
Ti(OR)4 + (2 + x) H 2 0 -* TiO2 x H 2 0 (oxide nanoparticle attached to substrate) + 4ROH
(Eq. 3.1)
The benefits to using the sol-gel method to deposit titanium dioxide films are that it is
cost effective, involves simple process chemistry and equipment, and preparation
conditions are tunable. Sol-gel has been used often in applications requiring coatings on
large surfaces as a result.
3.1.1 Experiments
The sol was prepared using titanium (IV) isopropoxide (TIP) (Aldrich, 99.999%) metal
precursor, acetylacetone (AcA) (Sigma-Aldrich, 99%), anhydrous isopropanol (IPA)
(Sigma-Aldrich 99.5%) and de-ionized (DI) water. AcA served as a catalyst 29 , while the
IPA and DI water was used to dissolve the metal precursor and affect the viscosity of the
sol. Anhydrous IPA was used so as to be able to precisely control the molar ratio of water
in solution. Measured quantities of each were added in the order indicated while the
solution was mixed (with a magnetic mixer) on a balance. It was carried out in room
temperature and in a nitrogen-infused glove box to minimize contaminants in the
solution. The sol was stored in sealed vials in a dry, ventilated area overnight (up to 12
hours) before being spun on thoroughly cleaned three-inch silicon wafer substrates at
1000 rpm. The cleaning protocol entailed a piranha clean to remove oxide formation on
the single crystal silicon, and rinse with methanol and isopropanol to increase
hydrophilicity. The films were dried in ambient air for one hour before annealing in a
450'C furnace for two hours. It was determined that the annealing time was sufficient to
dehydrate the gel and initiate crystallization.
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To develop the appropriate process protocol, the molar ratios of the chemicals were
varied accordingly and tested: for every 1 part of TIP, acetylacetone was varied from 1 to
3 parts, isopropanol was added in 1, 5, 9, 10, 12, or 14 parts, and the DI water was added
in 1 part. Below is the list of samples produced with their TIP: AcA: IPA: H20 ratios.
Table 3.1: Sol-gel sample matrix, ratios of TIP: AcA: IPA: H20
1:1:3:1 1:1:5:1 1:1:9:1
1:2:3:1 1:2:5:1 1:2:9:1 1:2:10:1 1:2:12:1 1:2:14:1
1:3:3:1 1:3:5:1 1:3:9:1 1:3:10:1 1:3:12:1 1:3:14:1
After annealing, the crystalline structures of the films were studied by glancing incidence
X-ray diffraction (XRD). XRD is a technique used to non-destructively reveal
information about the crystallographic structure of a material. The material is bombarded
with a parallel, monochromatic X-ray beam and the atoms in the lattice structure scatter
the waves in diffraction patterns particular to the type of crystal being analyzed. When
thin films are deposited on substrates, it becomes necessary to perform glancing
incidence (GI) XRD because the contribution to the diffraction pattern from the substrate
overshadows that of the film. GIXRD entails shallow angles of incidence and a longer
period of scattered wave detection as the signal detected is small for thin materials.
XRD measurements were carried out using a PANalytical X'Pert PRO Diffractometer
with monochromated Cu Ka (X= 0.1540598) incident radiation. Because glancing
incidence XRD was performed, the beam was incident at a shallow angle and the signal
was collected from 200 to 60' 20. The scan was taken at a rate of 0.0089' (20) per second
in order to obtain as many data points as possible from the thin film. The various
instrument parameters were programmed into the diffractometer using the X'Pert PRO
Data Collector software. After each 1 hour 15 minute scan, the Data Collector outputted
the diffraction pattern and it was compared to those of known, pure crystalline forms of
TiO 2 (anatase, rutile and brookite) found in the XRD database. For all the patterns of the
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samples tested, none exhibited any presence of brookite as expected and, therefore, the
reference pattern for brookite was not included in the figures following.
3.1.2 Results and discussion
The figures below are diffraction patterns of representative samples with TIP: AcA: IPA:
H20 ratios in Table 3.1. Not all the sol-gel solutions that were mixed successfully yielded
films. The samples that contained only one part AcA, ratios 1:1:3:1, 1:1:5:1, and 1:1:9:1,
spun onto the Si wafers but after the sintering and annealing step, it was found that
adhesion of the resulting film was very poor. The films were peeling off the substrate. A
likely cause was that there was insufficient acetylacetone to catalyze the reaction in Eq.
3.1, the alkoxides were not cleaved and, as a result, no covalent bonds formed between
the titanium dioxide and Si substrate. The samples with three parts IPA, ratios 1:2:3:1 and
1:3:3:1, were found to be too cracked after the annealing step to be tested with the XRD.
It was determined that the cause was the fact that the films were too viscous (this was
found to be true while the sol-gel was being spun onto the Si substrates) and the
evaporation of solvents during the sintering step caused enough stress in the film to
produce cracks. To circumvent this problem, sol-gel solutions with higher IPA content
were produced.
Figures 3.1, 3.2 and 3.3 shows the diffraction patterns of the films that were successfully
produced using the sol-gel process and exhibited sufficient crystallization. In Figure 3.1,
samples with 5 parts IPA, ratios 1:2:5:1 and 1:3:5:1 are compared to the peak locations
and relative peak intensities of pure rutile and anatase below the diffraction patterns. For
rutile TiO 2, peak locations are at 20 = 27.40, 36.10, 39.20, 41.20, 44.10, 54.30 and 56.60
and for anatase, the peak locations are at 20 = 25.30, 36.90, 37.80, 38.60, 48.10, 53.90 and
55.1. As can be seen in the figure, the dominant crystal phase in 1:2:5:1 is rutile while
there are only trace amounts of anatase (i.e. only the first, major anatase peak (101)
appears in the diffraction pattern). It is also noted that the peaks have relatively low
signal intensities indicating that there was not very much crystalline material in the film.
Sample 1:3:5:1, on the other hand, exhibits anatase TiO2 with trace amounts of rutile.
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Both diffraction patterns show that there is a significant amount of amorphous TiO 2 in
addition to the rutile and anatase crystal phases. This is indicated by the broad peak that
occurs near 20 = 290.
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Figure 3.1: XRD patterns of sol-gel samples made in ratios 1:2:5:1 and 1:3:5:1.
The samples 1:2:5:1 and 1:3:5:1 showed promising results, but the presence of
amorphous TiO2 and cracking exhibited by the films was not acceptable for future use in
the microfluidic device. The amorphous content can be explained by the fact that the sol-
gel solution was viscous and, as a result, too thick for the annealing step to sufficiently
crystallize the film. As mentioned earlier, it is necessary that the TiO 2 films be smooth to
prevent cell adhesion to the catalyst surface and clotting. Sol-gel mixtures were made
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with increased IPA in solution while maintaining the same amount of TIP, AcA and DI
water to see if the dilutions would decrease the viscosity and address the cracking
problem.
In Figure 3.2, the diffraction patterns of samples 1:2:9:1, 1:2:10:1, 1:2:12:1 and 1:2:14:1
were compared to the reference peaks of rutile and anatase TiO2. Figure 3.3 shows the
patterns of samples 1:3:9:1, 1:3:10:1, 1:3:12:1 and 1:3:14:1. While the samples exhibited
no cracking or peeling and were highly crystalline, all the diffraction patterns show that
there is significant amount of rutile TiO2 in each sample. Comparatively small traces of
anatase exist, but not enough for the films to have high catalytic activity. The goal is to
produce a film with 100% anatase content. It is possible that because the sol-gel solution
is diluted with large amounts of alcohol, the crystallization process is affected by the
evaporation of these solvents. With the sol-gel process, as it was carried out in these
experiments, the options are between low-crystallinity, cracked anatase TiO 2 and highly-
crystalline, well-formed rutile thin films.
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Figure 3.2: XRD patterns of sol-gel samples 1:2:9:1, 1:2:10:1, 1:2:12:1, 1:2:14:1.
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Figure 3.3: XRD patterns of sol-gel samples 1:3:9:1, 1:3:10:1, 1:3:12:1, 1:3:14:1.
3.2 Reactive D.C. magnetron sputtering
Sol-gel has proven to have its limitations in producing the requisite crystalline TiO 2
films. Consequently, reactive D.C. magnetron sputtering was explored as an alternative
method. Of the various physical deposition methods that are currently used, among them
evaporation, ion beams techniques and chemical vapor deposition (CVD), reactive
sputtering holds promise because of the high quality films that can be fabricated. In
reactive D.C. magnetron sputtering, a magnetron utilizes an electric field to trap ions
close to a metal target, inert gases in the chamber accelerate toward the surface of the
target, and it is eroded. The metal particles then interact with the oxygen present in the
chamber and the metal oxide molecules are deposited on the substrate. Reactive
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sputtering generally forms amorphous films due to the impact of high energy molecules
on film growth and the process involves slow deposition rates (on the order of 1 A/s).
However, a post-anneal step crystallizes the titanium dioxide very well and films
produced using this method are particularly robust.
3.2.1 Experiments
The titanium dioxide films produced for these experiments were done using an AJA
International, Inc. (N. Scituate, MA) Orion 5 high-vacuum sputtering system. The
vacuum chamber accommodated three magnetron guns - two RF and one DC - although
only the DC gun was used. A substrate holder for substrates of 100mm in diameter was
heated to temperatures ranging from room temperature (-250C) to 100 0C. The target was
a titanium disk (2 in diameter, purity 99.9%) connected to a mechanism for water-
cooling. Two gases-argon and oxygen-flowed through the chamber with the oxygen
content ranging from 10% to 20%. The chamber pressure varied between 1.6mTorr and
3.6 mTorr and was controlled by a turbo pump operating at a pumping speed of 1000 Hz
and the changing orifice of a throttle valve. The power supplied to the targets remained
constant at 250W. The film deposition was always carried out in reactive mode, with
oxygen always present in the deposition chamber. In this way, metal oxides of controlled
stochiometry can be stably deposited. Table 3.1 below shows the test array for the
experiments described.
The films were deposited on 3-inch single crystal silicon wafers and annealed for one
hour in a 450 0C anneal furnace in order to crystallize the films. The samples were then
tested using glancing incidence X-ray diffraction (GIXRD) using the same procedure that
was used for testing the sol-gel samples. Included in the table are the deposition rates
measured by the quartz crystal monitor (QCM) located in the sputtering unit prior to
depositing the films. All films were deposited such that the thickness was maintained at
50 nm. This proved thick enough to obtain a good diffraction pattern, with lots of signal
received from the sample, yet was not so thick that long deposition times were required.
In the next section, the results of the experiments are discussed and compared.
Table 3.2: Test array for film deposition experiments
Sample Deposition Pressure Teperature Deposition Ratepit I[mTo rr] i in Argonk/S]
1 1.6 5 RT 2.2
2 1.6 10 RT 2.1
3 1.6 15 RT 1.9
4 1.6 15 50 1.9
5 1.6 15 75 1.9
6 1.6 15 100 1.9
7 1.6 20 RT 1.6
8 2.6 15 RT 1.6
9 3.6 15 RT 1.5
10 3.6 15 50 1.3
11 3.6 15 75 1.4
12 3.6 15 100 1.4
3.2.3 Results and discussion
The figure below shows the diffraction patterns for samples 3, 8 and 9, under varying
deposition pressures, 15% 02 content in the chamber and with room temperature
substrates. In literature, it is reported that high vacuum deposition is essential for anatase
formation, but the exact deposition pressure recommended varies. Libl and colleagues
suggest a chamber pressure equal or less than 0.7 Pa or 5.25 mTorr.30 All films under
5.25 mTorr in the experiments that were carried out in Lbl's study crystallized to pure
anatase after annealing. Therefore, in these experiments, deposition pressures of 1.6
mTorr, 2.6 mTorr, and 3.6 mTorr were chosen. The measured film deposition rate for
pressures below 1.6 mTorr was too low to consider for film fabrication.
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Figure 3.4: XRD patterns of sputtered samples of varying deposition pressure.
Figure 3.4 clearly illustrates that a deposition pressure of 3.6 mTorr yields pure anatase
TiO 2. At pressures lower than 3.6 mTorr, the rutile content increases and anatase
decreases. The increase in rutile content could possibly be explained by the following
reasoning: At very low pressures, the Ti ions interact with the oxygen in the chamber and
bombard the substrate with high energy. It is known that the energy of the metal oxide
particles being deposited has an effect on how the crystals form in the film. The higher
the energy of the particles, the higher the rutile content will be. Another point to note is
that, in all the sputtered films, there is no amorphous TiO 2 and almost the whole film is
crystallized. This differs from the sol-gel experiments in which there was amorphous
content. In fact, the film deposited at 3.6 mTorr exhibits very high crystallinity because
the peaks in the diffraction pattern are relatively high and narrow.
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The deposition system that was used allowed for sample heating to temperatures up to
8000 C. We investigated the effect of sample temperature on the crystallization of the
TiO 2 films. Since as-deposited titanium dioxide films are generally amorphous and
annealing causes crystallization, it was hypothesized that a heated sample could promote
the growth of anatase as deposition occurred and a post-anneal step would not be
necessary. After the samples were deposited, our hypothesis proved incorrect; sample
heating also resulted in amorphous films as-deposited. We annealed the samples and
three diffraction patterns from the resulting films are shown in the following figure.
Figure 3.5 shows the effect of sample temperature on crystallization. As it turns out, the
higher the sample temperature, the more rutile TiO 2 forms after annealing. The film
sputtered at room temperature showed the best results, with all of the film exhibiting pure
anatase crystallization. It seems that the nucleation of rutile TiO2 is favored when the
impinging titanium dioxide particles, formed reactively in the region between the Ti
target and sample, have high energies. The formation of rutile is also promoted by the
presence of Ti atoms in the vapor phase, which is possible at higher sample temperatures.
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Figure 3.5: XRD patterns of sputtered samples of varying sample temperature.
Figure 3.6 shows the diffraction patterns of films deposited under 10%, 15% and 20%
oxygen content, at a deposition pressure of 1.6 mTorr and on samples at room
temperature. It has been shown that films sputtered at 1.6 mTorr form rutile when the
oxygen content is 10%, but the patterns shown below indicated that increasing the ratio
of oxygen to inert gas (Ar in this case) favors the formation of anatase after films are
annealed. As mentioned earlier, nucleation of rutile is promoted by the presence of Ti in
vapor phase in the vicinity of the substrate onto while the titanium dioxide is being
deposited. Increasing the ratio thus favors anatase formation because the Ti vapor is
minimized. The results below illustrate, however, that much more oxygen is required to
produce pure anatase and to obtain films of high crystallinity.
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Figure 3.6: XRD pattern of sputtered samples of varying oxygen content.
3.3 Conclusions
The experiments discussed in this chapter compare two different methods of titanium
dioxide film deposition. Sol-gel and reactive sputtering, one a wet-chemical technique
and the other a physical deposition method, were found to yield very different products.
Although sol-gel is an inexpensive and quick means of producing metal oxide films, it
was deemed difficult to obtain films that fit both criteria that were outlined in the
beginning of the chapter - highly crystalline anatase TiO 2 and smooth films. Although a
wet-chemistry protocol is easier to follow, there were several complications encountered
because the viscosity of the sol-gel solution, solvent evaporation and crystallization were
difficult to control.
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The preparation of titanium dioxide thin films using a sol-gel protocol was abandoned for
a more expensive and time-consuming process. Sputtering, however, has been found to
yield thin films that were mechanically robust and highly crystalline anatase in
composition. After performing the experiments, the protocol that was settled on was that
which formed the film of sample 9 in Table 3.1. The films were deposited using reactive
D.C. magnetron sputtering, at a power of 250W, under a deposition pressure of 3.6
mTorr, in a chamber that contained 15% 02 and 85% Ar gas and at room temperature.
The deposition rate remained roughly at 1.5 A/s. In Chapter 4, the next steps - where the
anatase titanium dioxide thin film developed is incorporated into a microfluidic device
for blood oxygenation - are discussed.
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In recent years, researchers have been investigating the possibility of using photocatalytic
oxygen generation to address deficiencies in pulmonary respiration. 31' 32' 33,34 In particular,
efforts have been made to reproduce a photoelectrochemical cell in a fluidic device for
blood oxygenation. In Chapter 2, the mechanism by which oxygen is produced in such a
cell, as well as how blood oxygenation occurs in vivo, were reviewed. In Chapter 3, the
photocatalyst film fabrication was explored. The present chapter describes the design of
the novel microfluidic device that is proposed and the experimental work that validates
its function.
The novel approach outlined here can be used to oxygenate whole blood and treat
patients with chronic and end-stage lung disease in real time. The goal is to create a self-
contained, mobile oxygen supply suitable for implantation in patients that will reduce the
complications they suffer from current treatments. Specifically, we focused on the
development of a highly efficient photocatalytic cell (PC) with the ability to continuously
oxygenate venous blood under steady-state conditions.
At the time the work discussed in this thesis was conducted, the only other researchers
investigating photocatalytic blood oxygenation were A. Subrahmanyam and his
colleagues at the Department of Physics in the Indian Institute of Technology in Chennai,
India. Our approach to the artificial respiration differs in several ways from theirs. First,
we are the first to integrate the photocatalytic semiconductor thin film into microfluidics.
The use of soft polymers, like polydimethylsiloxane (PDMS), in a device is beneficial
because of its biocompatibility and ease with which it can be molded into various channel
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geometries. Second, the ultimate design of the microfluidic device for artificial
respiration will be implanted in vivo and blood will be flowing continuously through it by
the pumping power supplied by the heart. Therefore, the transport of oxygen to the blood
is done in real-time, as it is in normal pulmonary function. The Subrahmanyam design
has the blood remaining stationary in a reservoir while photocatalysis takes place.
Our device design is outlined as follows.
4.1 Photocatalytic cell (PC) design and
fabrication
The photocatalytic cell that was designed is illustrated in Figure 4.1. It is composed of
three main components:
(1) a highly crystalline anatase TiO 2 thin film deposited onto a conducting indium tin
oxide (ITO) thin film to form a semiconducting junction of TiO 2/ITO,
(2) a platinum (Pt) electrode that is exposed to blood flowing through the channel and by
means of which a bias potential can be maintained, and
(3) microfluidic channels molded out of polydimethylsiloxane (PDMS)
The blood flowing in the microfluidic channel is in direct contact with the TiO 2 film, and
water in blood plasma (more than 90% of which is water by volume) is oxidized to
produce dissolved oxygen gas. During the fabrication process, TiO 2 is sputtered onto a
conductive ITO film that has already been deposited on the quartz substrate. Above the
fluidic channel is a platinum electrode that is deposited onto PDMS. Between the ITO
and Pt electrode, a bias potential is maintained to enhance the migration of electron
vacancies, or holes, to the photocatalyst/fluid interface so that oxidation reactions can
take place there. The bias also conducts away the electrons generated in the bulk of the
photocatalyst when the holes are created. The set-up of the cell in Figure 4.1 is analogous
to the photoelectrochemical cell in Figure 2.5 in Chapter 2.
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Figure 4.1: A) Schematic and B) photo of assembled device.
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4.1.1 ITO/TiO2 thin film deposition
The metal oxide thin films were deposited onto three-inch diameter quartz wafers (Mark
Optics Inc., Santa Ana, CA) which served as the substrates for the microfluidic devices.
Quartz glass (thickness of 700 iim + 100 [tm) was chosen because it has a transmittance
of approximately 96% in the UV range. Indium tin oxide was chosen for the conductive
layer because it has a 90% transmittance of UV light and a conductivity of about 104
S/cm. The operation of the device relies on the irradiation of the photocatalyst and, as
shown in Figure 4. 1A, the UV light must pass through the glass and ITO film before it
reaches the TiO 2 film. Therefore, a high transmittance for both materials is necessary.
As can also be seen from Figure 4. 1A, the bias voltage that is applied across the channel
relies on closing the circuit between the Pt electrode and the ITO layer. ITO was
patterned onto the substrate according the schematic in Figure 4.2. TiO 2 was patterned
only in the channel region where it is exposed to the blood. The channel for the design of
this proof-of-concept microfluidic device is simply rectangular, 4.5 mm in width and 25
mm in length, as the goal was to demonstrate device's capability of blood oxygenation.
The minus (-) sign in the figure below indicates that the anode of the electrical circuit is
the ITO film underneath the photocatalyst. Once the microfluidic device is assembled, the
Pt electrode (which serves as the cathode) will be connected to the U-shaped ITO film
that is denoted by the plus (+) sign in the figure below.
i *TiO, ouer ITO
+ - -mmmmml
Figure 4.2: Schematic of patterned ITO and TiO2 thin films. The (-) and (+) signs refer to
regions where electrical connections were made to close the electrical circuit.
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Patterning of the thin films was deemed necessary because, in previous designs, the metal
oxides were deposited onto the whole surface of the quartz and bonding was found to be
poor between the PDMS and substrate. Patterning has proven to be successful because it
allows the polymer to be plasma bonded directly to the glass.
The film deposition protocols of the ITO and TiO 2 are largely covered in Appendix A. To
summarize, each quartz wafer was cleaned and a photolithography protocol was carried
out to mask with photoresist the area in the negative of what is shown in Figure 4.2. The
substrates were then placed in the sputtering unit for metal oxide deposition. The main
challenge encountered during fabrication was the drying, cracking and hard-baking of the
photoresist due to ion-bombardment and raised temperatures in the sputtering chamber.
The substrates underwent two rounds of sputtering amounting to approximately one hour
in the chamber. After metal deposition, hard-baked photoresist cannot be removed easily
under standard protocol, requiring ultrasonication in a resist remover bath of up to 6
hours or, in some instances, overnight.
Two photoresists were tested to determine what would work best to circumvent this
problem. The first, NR7-3000P (Futurrex, Inc., Franklin, NJ), is a negative photoresist
chosen because it has a temperature resistance of up to 1800C and can be removed easily
with Resist Remover RR4 (Futurrex, Inc.). A test wafer patterned with 3-am-thick NR7-
3000P was sputtered with 200 nm of indium tin oxide and 50 nm of titanium dioxide, at a
temperature well below 1800 C, and it was discovered that the NR7-3000P was hard-
baked. Ultrasonicating the test wafer overnight did not remove the resist. It is presumed
that the resist was too thin, and with the deposition of the metal oxide films over the
resist, the remover could not lift it off.
The second resist that was tested was AZ-4620 (Shipley, Corp., Somerville, NJ), a
positive resist that is used often when an ultra-thick film is required for single-coat
processes. This resist was spun onto the test wafer to a thickness of 10 Jim and after the
photolithography steps, it was kept in a 900 C, humid chamber. The resist thickness, as
well as its increased moisture content, yielded a positive result. Following the sputtering
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of thin films on the test wafer (200 nm of ITO and 50 nm of TiO 2), the resist was
completely removed after five minutes of ultrasonication in an acetone bath. A possible
cause is that, during resist development, an undercut formed around the features, and
resist remover was able to flow underneath and lift off the resist. As a result of its
success, the positive photoresist AZ-4620 was used to mask future quartz substrates for
ITO and TiO 2 deposition. The protocol for the lithography steps above are elaborated
upon in Appendix A.
4.1.2 Electrode fabrication
To apply the bias voltage across the ITO/TiO 2 junction, a platinum electrode of the same
dimensions of the thin metal oxide films (4.5 mm (w) x 25 mm (1)) was deposited onto
PDMS above the channel. It is in direct contact with the blood. To fabricate the
electrodes, pieces of PDMS (25 mm (w) x 35 mm (1) x 5 mm (h)) were prepared using an
elastomer and curing agent (Sylgard 184, Dow Coming) mixed to a ratio of 15:1,
respectively, and they were hard-baked overnight at 800 C. Thin masks (-0.5 mm) were
made by spinning (475 rpm) PDMS mixed to a elastomer : curing agent ratio of 10:1 onto
a clean silicon wafer, baking at 800C and cutting out the shape of the electrode. The
masks were thermally bonded to the hard-baked PDMS for 15 min, again at 80C. The
metal deposition was performed using the same sputtering unit as was used for the ITO
and TiO 2 deposition, the AJA International, Inc. (N. Scituate, MA) Orion 5 high-vacuum
sputtering system. The details of the metal deposition are included in Appendix A.
Sputtering metals onto PDMS, much less masking of substrates with thin PDMS films, is
not standard practice. There were some challenges that were faced to fabricate a thin film
electrode on a polymer using a physical deposition process. As mentioned earlier the
temperatures of substrates within a sputtering chamber rise, and since PDMS is a polymer
the expansion and then shrinkage after metal deposition causes cracking. A cracked
electrode decreases the lifetime of the microfluidic device because it shorts the circuit
that maintains the bias voltage. The PDMS was hard-baked in order to circumvent this
problem, as it made the polymer stiffer. Before deposition of the Pt (of a thickness of 320
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nm), a thin 30 nm layer of Ti was deposited to promote the adhesion of the platinum to
the PDMS. Both improvements decreased the cracking significantly and produced
smooth metal film electrodes. After the metal deposition, the thin PDMS mask was
peeled off to reveal the electrode in the "T" shape shown in Figure 4.3(d). The "leg" of
the T is the extension that is connected to the ITO film, the cathode of the photocatalytic
cell. Figure 4.3(a-d) illustrates the steps of the platinum electrode fabrication.
4.1.3 Channel fabrication
In standard soft lithography, channels are often molded out of bulk PDMS by casting the
pre-baked polymer against a mold generating a negative replica. For the purposes of this
design, the channels are instead fabricated in the following manner: SU-8 (Microchem,
Newton, MA) molds contain the outlines of the channel in positive relief, with the
features at 100 [tm in height. As mentioned earlier, the channel is simply rectangular in
geometry: 4.5 mm (w), 25 mm (1) and 100 itm (0.1 mm) (h). PDMS (Sylgard 184, Dow
Coming), mixed in a 10:1 ratio of elastomer to curing agent, was spun onto the molds to
a thickness of 100lm. After curing, the solidified PDMS within the channel region was
peeled away to create a void through which the fluid flows. When assembling the device,
this PDMS "gasket" was sandwiched between the platinum electrode and the glass
substrate to form an enclosed channel. Figure 4.3 (e-h) illustrates the major steps of the
soft lithography process. Further fabrication details are discussed in Appendix A.
4.1.4 Device assembly
The photocatalytic cell was assembled according to the depiction in Figure 4.3, steps (i)
through (k). The electrode deposited on PDMS was aligned onto the channel and plasma
bonded, (i); the assembly was baked at 800 C for 5 min and gently peeled off the mold,
(j); and the holes to provide inlet and outlet ports to the fluidic device were punched into
the PDMS (not shown), the channel assembly was aligned onto the titanium dioxide on
the quartz substrate, and the device was plasma bonded. In order to connect the electrode
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Figure 4.3: Schematic view of fabrication steps to assemble the microfluidic device. (a-
d) denote the electrode fabrication; (e-h), the channel fabrication; and (i-k), device
assembly.
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to the cathode, a pearl of silver epoxy adhesive (MG Chemicals, BC, Canada) was placed
on the leg of the T-shaped electrode before assembly. The device was baked again for 10
min at 800C. Heparin, an anti-coagulant, was flowed through the fully assembled device
and stored overnight, or until blood experiments were conducted, at room temperature.
4.2 Testing oxidative capacity
Prior to experimentation with whole blood, it was important to perform tests to
qualitatively assess the oxidative capacity of the photocatalytic fluidic device. We wanted
to observe the effects of various flow rates and applied bias voltages on the device's
ability to oxidize water, and analyze how electrolysis may contribute to oxygen
production. Because this is a device operating in real-time, the fluid flow rates are a
contributing factor to how much oxygen is produced and binds to hemoglobin. The rates
are inversely proportional to the residence time, or the time it takes a fluid particle to
traverse the length of the fluid channel. It is clear that a longer residence time is
favorable; the Peclet number in such a case is very small and there is ample time for
diffusion of oxygen from the fluid/photocatalyst interface through the height of the
channel. However, in vivo, 5 liters of blood flows through the lung every minute and to
handle the large volume of blood, the device for blood oxygenation will need to operate
at higher flow rates.
The purpose of the bias voltage is to enhance photocatalytic activity. Initial experiments
aided in determining what the optimum bias for the operation of the microfluidic device
would be. During the design stage, it was a concern that the bias would induce
electrolysis of the water, such that it would not be determinable whether the blood was
being oxygenated by photo-induced water splitting or electrolysis. High voltages are also
a concern because of the potential damage to red blood cells and the initiation of blood
clotting, due to high fluid temperatures. The following experiments were conducted in
order to investigate the effect of various bias voltage.
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Methylene blue (MB) is an organic dye that serves as a redox indicator and has been used
in several applications to test photocatalytic activity.3 5,3 6,37 The molecular structure of
MB is shown in Figure 4.4. When in contact with the electron vacancies on the surface of
UV-illuminated titanium dioxide, oxidation of the MB molecule cleaves the aromatic
groups and the dye solution loses its blue color. For the experiments that are discussed as
follows, the dye's degradation was quantified by performing an absorbance measurement
with a spectrophotometer (SpectraMax M2e Microplate Reader) before and after one pass
through the microfluidic device, while fully operational. The MB dye (Sigma-Aldrich,
0.05 wt% in H20) has an absorbance is max = 665 nm and it was diluted in DI water to an
initial concentration of Co = 1 IM. The degradation of the dye, as determined from the
spectrophotometer reading, was expressed as the ratio of final dye concentration, C, to its
initial concentration, Co.
I +
Figure 4.4: The molecular structure of methylene blue, C16H18C1N 3S. [Reproduced from
Houas et al., 2007] 38
4.2.1 Bias voltage experiments
The flow of the dye solution was controlled by a Harvard Pump 11 plus syringe pump
(Harvard Apparatus, Holliston, MA) and the rates were set such that the residence times
for each were 7.5 s, 15 s, 30 s, 60 s, and 150 s. A microfluidic device fabricated with a 50
nm-thick TiO2 film was illuminated with UV light (Exfo, OmniCure 2000 Series), in the
manner shown in Figure 4.1A, at a distance of 8 cm from the quartz substrate. The UV
spot curing system used relayed light from a UV lamp with a peak wavelength at X = 365
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Figure 4.5: Photo of experimental set-up with UV optical fiber.
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nm via a 5 mm-diameter optical fiber at an intensity measured at 7.5 W/cm 2. The bias
voltage was applied between the platinum electrode and ITO using a voltage source
(Model 6517A Electrometer/High Resistance Meter, Keithley Instruments, Cleveland,
OH) and was varied from no bias to 5V, in one volt increments. For a better
understanding of the experimental set-up, please see Figure 4.5. A standard sterile 96-
well microplate was used to hold the samples for spectrophotometer measurement and
each plate included a control sample of MB at concentration Co. The results of the
experiments are shown in Figure 4.6 below.
1 - -no bias - 1V +2V -- 3V -- 4V - 5V
0.8
0.6
o
0.4
0.2 -1
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0 30 60 90 120 150
Residence time [s]
Figure 4.6: Effect of bias voltage on methylene blue degradation.
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Figure 4.6 shows methylene blue degradation, represented by the concentration of MB
normalized by its initial concentration, as a function of residence time. The results show
that the oxidation of the dye increases the longer the residence time within the
photocatalytic cell, as expected. The exponential decay of dye concentration indicates
that the oxidation reaction may be of first order and can be expressed by Eq. 4.1,
dCd= - C (Eq. 4.1)dt
where C is the concentration, t is residence time and K is the first-order rate constant. K is
a function of the experimental conditions-intensity of UV illumination of the
photocatalyst, photocatalyst thickness, initial dye concentration, and bias voltage. Since
the UV illumination, thickness and Co are kept constant, K is dependent only on the bias
voltage. The data for each set of bias experiments was fit, using the method of least-
squares, to the equation:
C =exp (- ) (Eq. 4.2)
Table 4.1 below shows the calculated decay rate constants and the corresponding R2
values for the fits. The no bias case shows the degradation of the dye from the oxidizing
effect of holes that have managed to migrate to the solution/photocatalyst interface
without recombining with free electrons. The x value for the device operating at 5V bias
is nearly ten times that of the no bias case, demonstrating that the bias voltage can greatly
enhance the photocatalytic effect. The data in Figure 4.6 and Table 4.1 also show that
there is little difference between the effect of bias voltages 3V, 4V and 5V since the
curves corresponding to those cases nearly lie on top of one another and the rate
constants are similar in value. As a result of these experiments, the microfluidic chips
from this point on were operated at 3V bias voltage.
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Table 4.1: Rate constants for methylene blue degredation under various bias voltages.
Bias Voltage Rate constant, K R value
No bias 0.0023 0.8625
1V 0.0039 0.9564
2V 0.0096 0.8804
3V 0.0172 0.8873
4V 0.0159 0.6999
5V 0.0209 0.9941
4.2.2 Electrolysis experiments
Methylene blue is capable of degradation through direct or indirect electrolysis 36, which
draws concern about the results obtained in the previous section for the bias voltage
experiments. It is possible that what is presumed to be oxidation by photocatalysis is
actually electrolysis-an issue that should be addressed since the same possibility exists
for water in blood. The following experiments were conducted in order to show the
contribution of electrolysis to methylene blue degradation.
Similar to the bias voltage experiments, MB solution at an initial concentration of Co was
pumped through two microfluidic devices such that the residence times were 7.5 s, 15 s,
30 s, 60 s, and 150 s. The devices differed in the following manner: during the metal
oxide film deposition part of chip fabrication, only ITO was deposited onto the substrate
of Device 1. No TiO 2 was deposited and, as result, the only means of MB degradation
would be the voltage supplied across the Pt electrode and ITO film. For Device 2, a 50
nm TiO 2 film was deposited on top of the ITO electrode. Three sets of experiments were
conducted: (1) one with Device 1, with no UV illumination and operating at 1V bias; (2)
another with Device 1, with no UV illumination and operating at 5V bias; and (3) one
with Device 2, illuminated with UV as described previously and operating at 3V bias.
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Figure 4.7: Effect of electrolysis on methylene blue degradation.
1
0.8
0.6
0.4
0.2
0
0 30 60 90 120
Residence time [s]
150
Chapter 4: Microfluidic Device Design and Experimentation 64
Figure 4.7 shows the data gathered from the electrolysis experiments. The normalized
concentration ratio is plotted as a function of the residence time. Under 1V bias and no
photocatalyst, MB shows no degradation with the concentration essentially remaining
constant at Co. Under 5V bias and no photocatalyst, there is some MB degradation, but
not nearly as much as there is under the effect of photocatalysis. Upon UV illumination,
the chip containing a 50 nm-thick TiO 2 film oxidizes the MB by nearly 80% during a
residence time of 150 s. These results put to rest the concern that electrolysis is mistaken
as photocatalysis and shows that MB degrades mostly due to the oxidation reaction.
The experimental results with methylene blue were promising. They showed that the
device as designed is capable of real-time photocatalytic oxidation of the fluid flowing
through it. The results provided us with a means of judging how best to operate the
device to achieve optimal electron-hole production (i.e. determining the optimum bias
voltage). The next, and vital step, is to demonstrate that blood oxygenation is possible
with the microfluidic device.
4.3 Blood oxygenation
Bovine blood obtained from a slaughterhouse (Blood Farm, Groton, MA) was used
for blood oxygenation experiments. The blood was about 36 hours old and treated as
follows: a solution of 20,000 units heparin in 40 ml sterile Dextrose (5%) was added
to approximately 200 ml of blood obtained from a single cow. The blood was then
gently stirred to incorporate the heparin into the fresh blood. This was done to
guarantee an activated clotting time (ACT) of approximately 400 seconds at room
temperature, an accepted value for a cardiopulmonary bypass procedure, 39 and
minimize blood clotting within the microfluidic device.
The device was also prepared to safeguard against clotting by flowing heparin through its
channels and storing the device in room temperature overnight. It was determined
necessary to follow this procedure especially for freshly fabricated devices, otherwise
protein adhesion would result immediately after blood started flowing through the
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channel. The plastic tubing (Masterflex@ Tygon@ tubing, Cole-Palmer) and the syringe
(60 mL Louer-Lok, BD) used to pump the blood through the chip were biocompatible;
the tubing connecting pins (18 gauge, New England Small Tube) were not so they were
stored in heparin and changed frequently between experiments.
After the blood and device preparation, the experiments were performed as follows: a
syringe was filled with approximately 25 mL of heparinized whole blood and tested using
a commercial blood gas analyzer (ABL 520, Radiometer, Denmark) to determine
hemoglobin saturation level (sO2 [%]), pH, carbon dioxide partial pressure (pCO2
[mmHg]), oxygen partial pressure (pO2 [mmHg]) and hemoglobin count (tHb [g/dL]).
The pH and pCO 2 were measured for monitoring purposes, but the other measurements
were made in order to calculate the oxygen content, Ca02, in blood using the Fick
principle:
CaO2  .tHb. (O)+ P- pO2  (Eq. 4.3)
where Ca02 is calculated in units of [mL 02/ 100 mL blood], a is the binding capability
of oxygen to hemoglobin (1.34 mL 02/ g Hb) and fl is the solubility of oxygen in blood
(0.0031 mL 02/ (100 mL blood - mm Hg)). The first term on the right hand side of Eq.
4.3 represents the oxygen bound to hemoglobin while the second term is the amount of
oxygen in solution. Preliminary experiments show that volume of dissolved gas in blood
plasma constitutes approximately one percent of the total oxygen content.
The blood was then pumped through the microfluidic device at a flow rate of 12.5
iL/mmin, corresponding to a residence time of 54 seconds. The experimental set-up was
the same as it was with the methylene blue experiments (see Figure 4.5). The UV spot
curing system illuminated the device from underneath at a distance of 8 mm from the
quartz substrate. The discharge tubing was submerged in a vial filled with -300 #tL
paraffin oil (OVOIL TM , Vitrolife, Sweden) and n = 3 samples (100 #L each) were
collected. The oil served as a barrier between the blood and the environment to prevent
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further oxygenation once the fluid flowed out of the device. The samples were then tested
by the blood gas analyzer once again to determine the oxygen content at the exit.
4.3.1 Blood oxygenation experiments
The goal of the first set of experiments was to observe the effect of the initial oxygen
saturation, sO2 [%], of the blood on its change in calculated oxygen content, CaO2, after
one pass through the microfluidic device. The s02 is the percentage of red blood cell
hemoglobin that has oxygen bound to it. The hypothesis is that the CaO2 should remain
the same regardless of the initial value of sO2; the production of oxygen from the
photocatalyst surface should remain constant with the same blood flow rate through the
device, UV illumination, and TiO 2 film thickness. In the case of the following
experiments, the flow rate was maintained at 12.5 UlJmin and the TiO 2 thickness was 50
nm.
The s02 was varied by aspirating the syringe containing the blood after each experiment
and allowing the fluid to exchange gases with the ambient air for five minutes. The s02
values were S1 = 23.6%, S2 = 34.4%, S3 = 45.0%, S4 = 64.0%, and S5 = 75.7%. The
results of the experiments are shown in Figure 4.8 below.
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Figure 4.8: Increase in blood oxygen content for various initial 02 saturation.
These preliminary results show that the microfluidic device used increased the blood
oxygen content by an average of 4.06 ± 0.32 mL 02/100 mL blood. As presumed earlier,
the initial saturation had little effect on the amount of oxygen binding to hemoglobin and
in solution, and the change in CaO2 value was approximately constant. In Chapter 2, it
was stated that in the lung the increase of oxygen is 6.5 mE 02/100 mL blood. With the
proof-of-concept microfluidic device, as it was designed, it is possible for us to
oxygenate blood two-thirds the amount the lung does. Also mentioned in Chapter 2 was
the fact that, in vivo, venous blood enters the lung at a sO02 level of 64% and leaves at
96%. In our experiments, sample S4 entered at 64.0% and exited the device at an average
sO02 value of 85.6%. Sample S5 entered at 75.7% and exited the device at an average s02
value of 96.6%. Results are quite close to the in vivo values. Granted, the microfluidic
device is operating at a flow rate much slower than that of the blood flow in the lung (5
Umin), but these are a very promising result nonetheless. With further improvements to
the device, it may be possible to fully oxygenate venous blood as the lung does and
ultimately to also handle the blood volume that the lung does.
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To provide some prospective on the results, Table 4.2 lists the oxygen producing capacity
of other photocatalytic fluidic devices for artificial respiration. Subrahmanyam et al have
a photocatalytic cell (PC) that does not oxygenate blood in real-time and produces 2.41 x
10-5 mmol 0 2/(cm 2 -min). 34 Our colleagues, Gilbert et al created a real-time fluidic PC
and produced nearly triple that amount, 6.25 x 10-5 mmol 0 2/(cm 2 min).3 1 Neither
device was a microfluidic device or had channel heights as small as ours (100 #m).The
microfluidic device for blood oxygenation produced an oxygen flux of 1.11 x 10-3 mmol
0 2/(cm 2 -min), two orders of magnitude larger than any other PC to date.
Table 4.2: Comparison of oxygen flux from different PC designs.
Subrahmanyam et Gilbert et al,
I 1~~~a '1)1 )ff7
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4.3.2 Experimental observations and issues
The first round of experiments was successful in demonstrating that the microfluidic chip
works; however, there were several experimental issues encountered and observations
made that ought to be discussed.
First, there was a concern that the photo-induced oxidation reaction would lower the pH
of the blood because of hydrogen ion evolution. This is a legitimate concern as the pH in
the body affects the function of various proteins and critical reactions. It was expected,
however, that the buffering capacity of the blood would maintain the pH at physiological
level, 7.4. Carbonic acid is the body's means of regulating the pH and its dissociation is
given by the Henderson-Hasselbalch equation:
H2 CO3 +-+ H + HCO (Eq. 4.4)
The experimental results validated the assumption. It was observed that average pH
values between inlet and outlet were nearly the same, 7.19 and 7.25, respectively. The
minor difference lies within one standard deviation and it was demonstrated that the
blood pH was not adversely affected by the photocatalytic effect.
The second observation, and one not so easily dismissed, was that the light intensity
reaching the photocatalytic film was perhaps a lot more than was needed for oxidative
holes to form. As mentioned earlier, the UV optical fiber emitted light at an intensity of
7.5 W/cm2 and, assuming no loss, the intensity of light reaching the surface of the device
was 2 W/cm 2. The film is essentially blasted with UV light. The devices that were
fabricated for blood experiments generally had a lifetime of four experiments before they
could no longer be used. Protein adhesion on the TiO2 contributed significantly to the
short lifetime of the devices. Protein adhesion and blood clotting occluded the channels to
the point where the hydraulic resistance prevented the flow of blood. Furthermore,
adhesion decreased the effective surface area of the photocatalyst. Flowing heparin
through the device between experiments made negligible difference once the adhesion
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had already taken place. The hypothesis was that the intensity of light was so high that
the fluid temperature rose and thus encouraged cell and protein adhesion, an issue
plaguing many biomedical devices.
A new UV light emitting device was designed so that the intensity would be tunable and
there would be minimal heat generation. Yang-Hyo Kim, a student in the Department of
Mechanical Engineering, made a light guide that would relay UV light (X= 365 nm) via
three LEDs directly to the area where the photocatalyst was deposited onto the quartz
substrate. Figure 4.9 is an annotated photo of the light guide. The LEDs were placed
under a diffuser to ensure that the light reached the device with uniform intensity. A sink
was placed underneath because the electrical components generated heat. The light guide
was connected to a DC power supply (Tenma, Model 72-6610) and the intensity of the
UV LEDs varied linearly with the supplied current. For all the experiments following this
point, the microfluidic device was directly attached to the light guide and the UV spot
curing system was no longer used. The change decreased the incidence of protein
adhesion and improved the lifetime of the devices.
Diffuser
UV LED
Heat sink
Figure 4.9: UV light guide
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4.3.3 UV light intensity experiments
The new UV light guide allowed a round of experiments that aided in determining the
minimum UV light intensity required to operate the microfluidic chip. The experimental
set-up is shown in Figure 4.10 (the voltage and current sources are not shown). Blood, at
an initial saturation of approximately 17%, flowed through a chip fabricated with a 50
nm-thick TiO2 film at a rate of 12.5 L/min. The blood was tested by the blood gas
analyzer before and after one pass through the device. Three samples of blood were
collected in vials of oil, as was done previously. The UV light intensity was varied (by
changing the current to the guide) from 10 mW/cm 2 to 90 mW/cm 2, in increments of 10
mW/cm 2 for each data point. Figure 4.11 provides the results.
Figure 4.10: Photo of experimental set-up with UV LED.
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Figure 4.11: Effect of UV light intensity on increase in blood oxygen level.
The plot above shows the effect of the light intensity, or irradiance, on the blood oxygen
content gain. As is evident, the average increase in CaO2 is approximately 4 mL 02/ 100
mL blood as it was when the UV light intensity 8 cm away from the chip was 7.5 W/cm2.
This indicates that the UV irradiation was nearly three orders magnitude larger than it
needed to be in order for the photocatalyst to produce the requisite number of oxidative
sites for oxygen production. Lowering the intensity of UV and moving the light source
closer to the film reduces the amount of power required to operate the device and
increases its efficiency.
The data also suggests that an irradiance of 20 mW/cm 2 is the optimum for oxygen
production for this device. The CaO2 increase at this UV intensity is 5.05 mL 02/ 100 mL
blood, approximately 1 mL 02/ 100 mL blood over the average. The reasons why the
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maximum occurs at this intensity is not known. However, the experiments following
proceed with the UV light intensity maintained at 20 mW/cm 2.
4.3.4 Film thickness experiments
The goal is to increase the oxygen output from the thin film photocatalyst and oxygenate
blood to the degree that it is done in the lung. TiO 2 thickness was assessed to determine
whether a thicker film, when irradiated by UV, would generate more electron-holes and
have a greater oxidative capacity. The following experiments involved five devices in
which the TiO 2 thicknesses were 50 nm, 100 nm, 150 nm, 300 nm and 400 nm. The UV
light intensity was 20 mW/cm 2 and the initial oxygen saturation level was approximately
30%. Similar to the experimental protocol for the methylene blue experiments, the flow
rates were varied to plot the increase in CaO2 as a function of the residence time of blood
in the cell. The flow rates were 100 IL/min, 50 ,IL/min, 25 IL/min, 12.5 IL/min and
6.25 iL/min corresponding to residence times of 6.75 s, 13.5 s, 27 s, 54 s and 108 s,
respectively. To obtain more accurate results, the blood collected after one pass through
the device provided a sample size of n = 10. As always, the samples were tested using the
blood gas analyzer and the increase in Ca0 2 was calculated from the data collected.
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Figure 4.12: Effect of titanium dioxide film thickness on blood oxygenation.
Figure 4.12 displays the results obtained from the experiments outlined above. As one
would expect, the longer the residence time within the device the greater the increase in
the blood's oxygen content. All five films oxygenated blood to similar levels at low
residence times (high flow rates) but as the residence times increased the plots diverged
to indicate a marked difference between the oxygen outputs of the TiO 2 films. As
expected the dissolved oxygen production increased with thickness, with the 50 nm film
performing the poorest and the 300 nm performing the best, producing an average of 3.73
mL 02/ 100 mL blood and 5.52 mL 02/ 100 mL blood, respectively, at a residence time
of 108 s. Interestingly, the 400 nm film produced 5.31 mL 02/ 100 mL blood for the same
residence time, within one standard deviation of the 300 nm value.
The lack of improvement despite the 100 nm increase in TiO 2 thickness could be an
indication that a thickness of 300 nm thickness yields a limit to the oxygen production of
13.5 108
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the TiO 2 film. In fact, it has been proposed that the optimum thickness for a titanium
dioxide thin film is on the order of the wavelength of UV light, 365 nm.14 '18 The exact
reasons are unknown at present. Considering the results obtained and represented in
Figure 4.12, it is plausible. As a result, it is recommended to use a TiO2 film thickness of
approximately 350 nm for future devices.
4.4 Conclusions
This chapter covered the design of the microfluidic device for artificial respiration and
the experimentation that was done to validate its function. The results presented have
shown that although the device cannot produce, as of yet, the amount of oxygen that is
transferred to the lung in vivo, it is capable of producing 4.06 mL 02/ 100 mL blood with
a 50 nm TiO 2 film and a flow rate of 12.5 jlUmin. The increase in oxygen content is
almost two-thirds of that which is transferred in the lung, 6.5 mL 02/100 mL blood. We
have also achieved a maximum CaO2 value of 5.52 mL 02/ 100 mL blood with a device
fabricated with a 300 nm film and blood flowing at a rate of 6.25 /L/min. In the process
of conducting these experiments, we have also determined the optimum conditions under
which to operate the microfluidic device-a bias voltage of 3 V and illumination of TiO2
with 20 mW/cm 2 UV light. The results for the single-layer microfluidic device are an
excellent starting ground for a second generation device that could be capable of
sustaining the respiration of a small animal or, perhaps, even a human.
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Chapter 5
Summary and Future work
The sobering statistics on the prevalence of lung disease and the lack of appropriate
therapies for sufferers of acute and chronic symptoms encouraged the development of a
microfluidic device for artificial respiration. This thesis discusses a bulk of the research
that was conducted in order to produce a device with a high yield of dissolved oxygen gas
through photocatalytic water splitting and to validate its capability to oxygenate whole
bovine blood. The artificial respiration project lies at the intersection of several
engineering disciplines - materials science, nanoengineering, fluid mechanics, mass
transfer and optics, to name a few - and, therefore, there are many directions that could
be taken to explore how best to create an efficient photocatalytic lung replacement.
The goals outlined in the introduction are to (1) optimize the function of the thin film
photocatalyst so that it can produce enough oxidative sites for oxygen production and (2)
integrate the photocatalyst and microfluidics components seemlessly to create a device
for real-time blood oxygenation. In Chapter 3, the various methods of titanium dioxide
deposition, and their advantages and disadvantages, were discussed. Two methods for
thin metal oxide film fabrication, sol-gel and reactive D.C. magnetron sputtering, were
chosen to perform experiments to determine which method and what type of protocol will
yield highly crystalline and smooth films. Reactive sputtering was found to produce
robust and crystalline anatase films that promise high photocatalytic activity.
In Chapter 4, the design of a complete microfluidic device incorporating the
photocatalyst was discussed. The challenges in fabricating the device stemmed from
having to create a microfluidic chip that was an analogue of an electrochemical cell. The
photocatalytic cell (PC) contained a fluid channel, a Pt electrode that served as the
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cathode and ITO/ TiO2 junction that served as the anode. Standard microfabrication
techniques were used and some new techniques were developed to realize the design that
was proposed. To validate the function of the PC, a redox indicator, methylene blue
(MB), was initially used. In later experiments, however, bovine blood was used as the
oxygen carrier and the oxygen producing capability of the devices were assessed.
The results are very promising. Preliminary blood oxygenation tests show that a chip
fabricated with a 50 nm-thick titanium dioxide film and with blood flowing through it at
a rate of 12.5 IlUmin produces an average of 4.06 mL of oxygen per 100 mL of blood.
That translates to an oxygen flux of 1.11 x 10-3 mmol 02/ (cm 2 . min), more than two
orders of magnitude larger than that of any other fluidic device for artificial respiration to
date. Further experiments show that it is also possible to produce up to 5.52 mL 02/100
mL blood in a device with a 300 nm film. That nearly reaches the value of 6.5 mL 02/
100 mL blood, which is the oxygen transfer that occurs in the lung.
Before implanting the device into a patient with lung disease, there are a few things to
consider. The blood flowing through the human lung is pumped by the heart at a rate of
five liters per minute. In order to oxygenate venous blood after it enters the lung to
oxygen saturation levels of arterial blood, oxygen from the environment must diffuse
through three million alveoli at a rate of 313 mU min. Since the rate of bovine blood
through the microfluidic device is fairly low (12.5 jlUmin), the chip with 50 nm of TiO2
produces only 3.05 x 10-2 mL 02 per minute. If this device where to sustain human life, it
would need to be approximately one square meter. Therefore, there is still a good deal of
work to be done to move towards implanting a microfluidic blood oxygenator into a
human patient.
Future steps to improve the device's function must include the development of a
multilayer device to accommodate the large pulmonary blood flow rate and to provide the
surface area necessary to produce the requisite volume of oxygen. Currently, a two-layer
microfluidic device is being developed in the hope that the design concept can be
extended to a device of n layers. The main design challenge is the following:
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Each fluidic layer of the device is independent from the other. Each channel must have
access to a thin film photocatalyst for oxygen production and that means that UV light
must be relayed to each photocatalyst layer. A UV light guide, made of a thin (-0.5 mm)
plate of quartz or some type of polymer, that can be illuminated from its edge and emit
light from its two planar faces is proposed to irradiate the thin titanium dioxide films for
electron-hole production. It is also desired to sputter the ITO and TiO 2 films directly onto
this light guide; therefore, the materials used ought to be easily fabricated and
inexpensive as they will be disposable. If there are n layers, then an array of /2 n light
guides are required. A means of relaying UV light to each one from an external source is
also required. Distancing the source is desirable because any heat generating electrical
elements will not be in close contact with the blood. However, there will be issues due to
the intensity loss from total internal refraction. The development of the optics component
alone is complex enough to warrant a separate design project.
There are limits to how effectively a single-layer device can function. If an implantable,
self-contained real-time blood oxygenator is the objective, a multi-layer device is
essential. A multi-layer device will increase the photocatalyst surface area to device
volume ratio, driving its efficiency closer to that of a real lung. Although the artificial
respiration project is far from complete, the work that is presented in this thesis is a
stepping stone towards the realization of a lung replacement. The microfluidic device for
blood oxygenation will ultimately have a huge impact in the fields of bioengineering and
bioMEMS, microfluidics and medicine.
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Appendix A
Microfluidic device fabrication
A. 1 ITO/TiO2 thin film deposition
The ITO and TiO2 films were patterned onto quartz glass wafers (3" diameter and 700
ttm thick) and the wafers were cut into slides to produce individual substrates for the
microfluidic devices. The following is a detailed protocol of the fabrication.
Each quartz wafer (Mark Optics Inc., Santa Ana, CA) was cleaned using a three-step
solvent rinse, first with acetone, followed by methanol and then with isopropanol. The
wafers were dried with nitrogen and baked at 150C in order to eliminate any residual
solvents. AZ-4620 positive photoresist (Shipley, Corp., Somerville, NJ) was spun onto
the clean wafer at a rate of 1500 rpm for 60 s to obtain a thickness of 10 Itm. The wafer
was then placed for one hour in a 900 C oven, along with a dish of water to maintain a
humid environment inside the oven. This was done to prevent the resist from drying out.
Photolithography was performed using a dark-field high resolution transparency mask,
printed at 3550 dpi (Mikacolor, CA). The mask is shown in Figure A.1. After the bake,
the wafer was exposed through the transparency with the MJB3 Broadband Mask Aligner
(Karl Suss, VT) with an exposure rate of approximately 3 mW/ cm 2 for 36 s. The wafer
was then placed in a dish of MIF440 developer for 5 min, gently agitated, and then rinsed
with DI water. The quartz was masked with photoresist except for the areas where the
ITO and TiO 2 were to be deposited, as shown in Figure A.1.
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Figure A.1: Transparency mask for quartz substrate.
The sputtering protocol is as follows: The wafer was placed in the deposition chamber of
the Orion 5 high-vacuum sputtering system (AJA International, Inc., N. Scituate, MA)
and the chamber was pumped down using a turbopump operating at 1000 Hz. Argon gas
was introduced into the chamber at 12 sccm and the deposition pressure was set to 3
mTorr. The plasma around an ITO target, powered with an RF gun running at 215 W,
was ignited. A 30 min run deposited approximately 200 nm of ITO onto the substrate.
After removing the wafer from the sputtering chamber, the areas where ITO needed to be
exposed to make electrical connections were masked by manually swabbing AZ-4620
onto those areas. The wafer was baked again at 90'C.
Titanium dioxide was deposited on top of the ITO using the protocol developed in
Chapter 3: the wafer is placed in the sputtering unit, 02 gas at 1.8 sccm and Ar gas at 10.2
sccm flowed into the chamber, and the deposition pressure was set to 3.6 mTorr. The Ti
target powered by the DC magnetron gun ran at 250 W. The reactive sputtering
deposition rate was roughly around 1.5 A/s. The thickness of TiO 2 was varied and thus
the deposition times varied.
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After the second round of sputtering, the wafer was placed in an acetone bath and cleaned
in an ultrasonicator for 5 min. At that point, the resist was removed to reveal ITO and
TiO2 in the desired patterns (see Figure 4.2). The wafer was annealed in an annealing
furnace at 450C for 1 hour and it was diced to produce three identical substrate slides 18
mm in width and 54 mm in length.
A.2 Electrode deposition
The masking of the thick PDMS pieces that constituted the electrodes was covered in
Chapter 4. The deposition of the thin metal films was carried out as follows: The PDMS
substrates were placed in the deposition chamber of the Orion 5 sputtering unit equipped
with pure Ti and Pt metal targets (2 in diameter, purity 99.9%). The chamber pressure
was maintained at 3 mTorr and Ar gas flowed through at a rate of 12 sccm. The Ti target
was powered by a DC gun at 250 W and a 30 nm film was deposited onto the PDMS at a
rate of 0.8 A/s. The DC gun was then powered down and the plasma was reignited around
the Pt target. It was powered by an RF gun at 215 W and a 320 nm thin film of Pt was
deposited at a rate of 2.8 A/s. The substrates were then removed from the sputtering unit
and unmasked.
A.3 Channel fabrication
The channels were fabricated using soft lithography techniques. The molds were made by
producing the outlines of the channel in positive relief in SU-8 50 (Microchem) on 3" Si
wafers (Silicon Quest). Each silicon wafer was cleaned with solvents (acetone, methanol,
and isopropanol), dried with nitrogen, and baked at 1500 C on a hotplate to evaporate any
residual solvents. SU-8 50 was spun onto the wafer rotating at 1000 rpm to obtain a resist
thickness of 100 tim. A pre-bake of 10 min on 65°C hotplate and 30 min on a 95 0 C was
required. Figure A.2 shows the portion of the mask that is the negative of what appears
on the wafer. The channel is rectangular (4.5 mm (w) and 25 mm (1)) except that there are
tapered extensions on either end of the channel. These were added into the channel for
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the inlet and outlet in order to allow for developing flow and to minimize sudden
expansions or contractions in cross-sectional area. The wafer was then exposed for four
minutes by the MJB3 Broadband through the mask, which contained outlines for two
channels. A post-bake of 1 min at 65C and 10 min at 950 C further cross-linked the
exposed SU-8. The wafer was then developed by means of an acetone spray. The mold
was complete.
As mentioned in Chapter 4, the channel that is fabricated is actually a "gasket" that will
lie between the PDMS with the deposited electrode. Therefore, PDMS (Sylgard 184,
Dow Coming) mixed to an elastomer to curing agent ratio of 10:1 was spun onto the
mold to a thickness of 100 Im, the channel height. After baking for 2 hours at 800 C, the
PDMS in the region within the channel was peeled away. Thus, the channel in gasket
form was fabricated.
Figure A.2: Transparency mask for channel.
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